Novadiscovery Company

novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enabling scientists and biotech, pharma companies to predict drug efficacy and create the target combination.
Technology: Artificial Intelligence, Biotechnology, CRM, Health Care, Information Technology, Medical
Industry: Data Processing, Clinical Development
Headquarters: Lyon, Rhone-Alpes, France
Founded Date: 2010-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 8576734
Estimated Revenue: Less than $1M
Last Funding Date: 2021-02-16
Last Funding Type: Series A

Visit Website
https://www.twitter.com/novadiscovery
Register and Claim Ownership